Surgical & Medical Instruments & Apparatus Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Surgical & Medical Instruments & Apparatus
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2019-02-13 | UTMD | Utah Medical Products Inc | Payne Barbara A | Dir | S - Sale | $92.28 | -2,468 | 21,364 | -10% | -$227,749 | |||||
| M | 2019-02-14 | SPNE | Seaspine Holdings Corp | Essig Stuart | Dir | S - Sale | $16.09 | -33,952 | 0 | -100% | -$546,128 | |||||
| DM | 2019-02-13 | ABMD | Abiomed Inc | Sutter Martin P | Dir | S - Sale+OE | $360.16 | -20,000 | 180,491 | -10% | -$7,203,110 | |||||
| M | 2019-02-13 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +20,521 | 18,256,452 | 0% | +$15,014 | |||||
| D | 2019-02-13 | IRTC | Irhythm Technologies, Inc. | Vort David A | EVP, Sales | S - Sale+OE | $90.84 | -5,044 | 18,802 | -21% | -$458,180 | |||||
| D | 2019-02-13 | IRTC | Irhythm Technologies, Inc. | Garrett Matthew C. | CFO | S - Sale+OE | $90.10 | -20,203 | 20,204 | -50% | -$1,820,290 | |||||
| M | 2019-02-11 | PDEX | Pro Dex Inc | Swenson Nicholas John | Dir, 10% | S - Sale | $15.69 | -25,561 | 1,042,790 | -2% | -$401,171 | |||||
2019-02-11 | DXCM | Dexcom Inc | Sayer Kevin R | Pres, CEO, COB | S - Sale | $148.90 | -6,000 | 308,837 | -2% | -$893,400 | ||||||
2019-02-13 | PDEX | Pro Dex Inc | Charlton Alisha | CFO | S - Sale | $15.81 | -2,114 | 4,778 | -31% | -$33,419 | ||||||
2019-02-13 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $16.04 | -400 | 478,962 | 0% | -$6,415 | ||||||
| M | 2019-02-11 | SPNE | Seaspine Holdings Corp | Essig Stuart | Dir | S - Sale | $16.09 | -31,148 | 33,952 | -48% | -$501,312 | |||||
| D | 2019-02-11 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $97.18 | -6,651 | 296,622 | -2% | -$646,330 | |||||
| DM | 2019-02-11 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale+OE | $69.42 | -5,000 | 107,770 | -4% | -$347,075 | |||||
| D | 2019-02-12 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Pres, Rhythm Mgmt | S - Sale+OE | $40.00 | -44,236 | 266,360 | -14% | -$1,769,440 | |||||
| D | 2019-02-11 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $49.59 | -5,000 | 60,000 | -8% | -$247,950 | |||||
| D | 2019-02-11 | MMM | 3M Co | Bauman James L | EVP | S - Sale+OE | $200.24 | -16,065 | 24,403 | -40% | -$3,216,804 | |||||
2019-02-08 | DXCM | Dexcom Inc | Murphy Patrick Michael | SVP Legal Affairs | S - Sale | $142.76 | -400 | 29,308 | -1% | -$57,104 | ||||||
| M | 2019-02-11 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $15.65 | -20,749 | 479,362 | -4% | -$324,789 | |||||
| D | 2019-02-11 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale+OE | $5.86 | -2,783 | 60,825 | -4% | -$16,313 | |||||
| D | 2019-02-11 | TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | S - Sale+OE | $3.36 | -3,005 | 69,704 | -4% | -$10,097 | |||||
| D | 2019-02-11 | TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | GC | S - Sale+OE | $3.36 | -3,005 | 57,237 | -5% | -$10,097 | |||||
| D | 2019-02-11 | TTOO | T2 Biosystems, Inc. | McDonough John | Pres, CEO | S - Sale+OE | $3.36 | -8,134 | 448,220 | -2% | -$27,330 | |||||
2019-02-08 | DXCM | Dexcom Inc | Murphy Patrick Michael | SVP Legal Affairs | S - Sale | $142.76 | -400 | 29,308 | -1% | -$57,104 | ||||||
2019-02-11 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +10,368 | 18,235,931 | 0% | +$7,558 | ||||||
2019-02-08 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +4,768 | 18,225,563 | 0% | +$3,462 | ||||||
| D | 2019-02-07 | MMM | 3M Co | Vrohidis Ippocratis | VP, CAO | S - Sale+OE | $199.51 | -8,153 | 786 | -91% | -$1,626,635 | |||||
| D | 2019-02-07 | MMM | 3M Co | Gangestad Nicholas C | SVP, CFO | S - Sale+OE | $201.34 | -4,681 | 30,691 | -13% | -$942,450 | |||||
| D | 2019-02-08 | MMM | 3M Co | Keel Paul A | SVP | S - Sale+OE | $199.14 | -9,410 | 13,599 | -41% | -$1,873,924 | |||||
| D | 2019-02-07 | MMM | 3M Co | Vale Michael G. | EVP | S - Sale+OE | $199.29 | -8,906 | 42,699 | -17% | -$1,774,919 | |||||
| D | 2019-02-07 | MMM | 3M Co | Lindekugel Jon T | SVP | S - Sale+OE | $199.63 | -5,940 | 10,475 | -36% | -$1,185,791 | |||||
| D | 2019-02-07 | MMM | 3M Co | Bushman Julie L | EVP | S - Sale+OE | $199.90 | -3,123 | 34,373 | -8% | -$624,295 | |||||
2019-02-07 | MMM | 3M Co | Bushman Julie L | EVP | S - Sale | $199.66 | -5,829 | 37,496 | -13% | -$1,163,809 | ||||||
2019-02-07 | MMM | 3M Co | Bushman Julie L | EVP | S - Sale | $199.38 | -4,220 | 43,325 | -9% | -$841,392 | ||||||
| M | 2019-02-06 | SYK | Stryker Corp | Hutchinson Michael Damon | VP, GC | S - Sale | $180.49 | -15,995 | 6,960 | -70% | -$2,886,876 | |||||
2019-02-07 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.72 | +2,300 | 18,220,795 | 0% | +$1,658 | ||||||
2019-02-05 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $53.92 | -37,946 | 687,043 | -5% | -$2,046,136 | ||||||
| DM | 2019-02-04 | ABMD | Abiomed Inc | Sutter Martin P | Dir | S - Sale+OE | $350.09 | -30,000 | 200,491 | -13% | -$10,502,635 | |||||
| D | 2019-02-05 | PODD | Insulet Corp | Colleran David | SVP, Secretary, GC | S - Sale+OE | $80.72 | -6,834 | 34,133 | -17% | -$551,640 | |||||
| M | 2018-10-01 | SRDX | Surmodics Inc | Maharaj Gary R | Pres, CEO | S - Sale | $65.52 | -7,833 | 167,034 | -4% | -$513,189 | |||||
| D | 2019-02-01 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale+OE | $66.04 | -3,044 | 107,770 | -3% | -$201,026 | |||||
2019-02-04 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.67 | +3,636 | 18,218,495 | 0% | +$2,451 | ||||||
| D | 2019-02-04 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale+OE | $93.50 | -4,457 | 118,002 | -4% | -$416,730 | |||||
| DM | 2019-01-31 | TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | GC | S - Sale+OE | $3.43 | -2,759 | 54,428 | -5% | -$9,461 | |||||
| DM | 2019-01-31 | TTOO | T2 Biosystems, Inc. | McDonough John | Pres, CEO | S - Sale+OE | $3.43 | -14,338 | 439,688 | -3% | -$49,165 | |||||
| DM | 2019-01-31 | TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | S - Sale+OE | $3.43 | -6,351 | 66,875 | -9% | -$21,778 | |||||
| D | 2019-02-01 | BSX | Boston Scientific Corp | Pierce David A | EVP,Pres MedSurg | S - Sale+OE | $38.15 | -5,000 | 24,201 | -17% | -$190,750 | |||||
| DM | 2019-02-01 | NVCR | Novocure Ltd | Ambrogi Michael J. | COO | S - Sale+OE | $49.21 | -58,500 | 146,558 | -29% | -$2,878,847 | |||||
| M | 2019-01-31 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $53.07 | -52,054 | 724,989 | -7% | -$2,762,496 | |||||
2019-02-01 | BAX | Baxter International Inc | Stallkamp Thomas T | Dir | S - Sale | $73.75 | -1,638 | 30,380 | -5% | -$120,803 | ||||||
2019-02-04 | SYK | Stryker Corp | Fink M Kathryn | VP, CHRO | S - Sale | $176.77 | -180 | 5,859 | -3% | -$31,819 | ||||||
| D | 2019-01-31 | BAX | Baxter International Inc | Mason Jeanne K | SVP, HR | S - Sale+OE | $72.00 | -37,274 | 97,382 | -28% | -$2,683,728 | |||||
| D | 2019-01-31 | SYK | Stryker Corp | Francesconi Louise | Dir | S - Sale+OE | $177.20 | -9,477 | 18,277 | -34% | -$1,679,353 | |||||
2019-01-31 | SYK | Stryker Corp | Doliveux Roch | Dir | P - Purchase | $177.26 | +46 | 19,695 | 0% | +$8,154 | ||||||
| D | 2019-02-01 | RMD | Resmed Inc | Hollingshead James | Pres, Sleep Business | S - Sale+OE | $95.09 | -1,600 | 82,089 | -2% | -$152,144 | |||||
| D | 2019-01-31 | PODD | Insulet Corp | Colleran David | SVP, Secretary, GC | S - Sale+OE | $80.00 | -4,826 | 34,133 | -12% | -$386,080 | |||||
| D | 2019-01-31 | MMM | 3M Co | Thulin Inge G | Exec COB | S - Sale+OE | $200.03 | -13,290 | 232,076 | -5% | -$2,658,348 | |||||
| D | 2019-01-30 | MMM | 3M Co | Thulin Inge G | Exec COB | S - Sale+OE | $200.00 | -13,499 | 232,076 | -5% | -$2,699,862 | |||||
2019-01-29 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $136.69 | -1,086 | 10,077 | -10% | -$148,446 | ||||||
2019-01-30 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $92.30 | -3,000 | 91,390 | -3% | -$276,900 | ||||||
| D | 2019-01-30 | IRTC | Irhythm Technologies, Inc. | Sung Derrick | EVP, Strat Corp Development | S - Sale+OE | $84.00 | -2,000 | 25,258 | -7% | -$168,000 | |||||
| M | 2019-01-28 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $53.10 | -67,021 | 777,043 | -8% | -$3,559,040 | |||||
2019-01-30 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.68 | +8,000 | 18,214,859 | 0% | +$5,448 | ||||||
| DM | 2019-01-28 | IRTC | Irhythm Technologies, Inc. | Sung Derrick | EVP, Strat Corp Development | S - Sale+OE | $84.03 | -10,125 | 25,258 | -29% | -$850,851 | |||||
| D | 2019-01-25 | ABMD | Abiomed Inc | Weber David M | COO | S - Sale+OE | $351.47 | -24,000 | 163,339 | -13% | -$8,435,192 | |||||
| A | 2018-12-17 | REPR | Repro Med Systems Inc | Manko Joseph M. Jr. | Dir, 10% | P - Purchase | $1.20 | +45,000 | 11,274,191 | 0% | +$54,000 | |||||
2019-01-27 | DRIO | Dariohealth Corp. | Shaked Yoav | Dir | P - Purchase | $0.00 | +10,250 | 56,968 | +22% | +$0 | ||||||
2019-01-27 | DRIO | Dariohealth Corp. | Raphael Erez | CEO, 10% | P - Purchase | $0.00 | +61,969 | 2,154,945 | +3% | +$0 | ||||||
2019-01-27 | DRIO | Dariohealth Corp. | Karah Hila | Dir | P - Purchase | $0.00 | +10,250 | 105,883 | +11% | +$0 | ||||||
2019-01-27 | DRIO | Dariohealth Corp. | Kamer Allen | Dir | P - Purchase | $0.00 | +6,250 | 1,452,244 | 0% | +$0 | ||||||
2019-01-27 | DRIO | Dariohealth Corp. | Moller Glen | Dir | P - Purchase | $0.00 | +5,231 | 5,231 | New | +$0 | ||||||
2019-01-28 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.69 | +3,500 | 18,206,859 | 0% | +$2,398 | ||||||
| D | 2019-01-28 | ICUI | Icu Medical Inc/de | Swinney Robert S | Dir | S - Sale+OE | $242.19 | -1,500 | 19,165 | -7% | -$363,285 | |||||
| DM | 2019-01-24 | NVCR | Novocure Ltd | Longsworth Todd Christopher | GC | S - Sale+OE | $49.03 | -26,874 | 21,305 | -56% | -$1,317,731 | |||||
| D | 2019-01-25 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $50.00 | -20,000 | 60,000 | -25% | -$1,000,000 | |||||
| D | 2019-01-25 | NVCR | Novocure Ltd | Groenhuysen Wilhelmus Cm | CFO | S - Sale+OE | $49.20 | -35,000 | 37,149 | -49% | -$1,722,000 | |||||
2019-01-23 | GNMK | Genmark Diagnostics, Inc. | Stier Eric | SVP, GC | S - Sale | $5.90 | -3,596 | 183,733 | -2% | -$21,216 | ||||||
2019-01-23 | GNMK | Genmark Diagnostics, Inc. | McNally James B. | SVP, Sales, Marketing | S - Sale | $5.90 | -4,730 | 175,492 | -3% | -$27,907 | ||||||
2019-01-23 | GNMK | Genmark Diagnostics, Inc. | Massarany Hany | Pres, CEO | S - Sale | $5.90 | -15,166 | 1,216,630 | -1% | -$89,479 | ||||||
2019-01-23 | GNMK | Genmark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | S - Sale | $5.90 | -3,974 | 367,487 | -1% | -$23,447 | ||||||
2019-01-23 | GNMK | Genmark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | S - Sale | $5.90 | -3,974 | 146,495 | -3% | -$23,447 | ||||||
| M | 2019-01-23 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $52.62 | -62,870 | 844,064 | -7% | -$3,308,317 | |||||
2019-01-23 | GNMK | Genmark Diagnostics, Inc. | Mendel Scott | CFO | S - Sale | $5.90 | -5,297 | 324,235 | -2% | -$31,252 | ||||||
| D | 2019-01-25 | TNDM | Tandem Diabetes Care Inc | Sheridan John F | EVP, COO | S - Sale+OE | $45.26 | -20,000 | 666 | -97% | -$905,178 | |||||
| D | 2019-01-23 | NVCR | Novocure Ltd | Groenhuysen Wilhelmus Cm | CFO | S - Sale+OE | $47.35 | -35,000 | 37,149 | -49% | -$1,657,250 | |||||
| D | 2019-01-23 | NVCR | Novocure Ltd | Danziger Asaf | CEO | S - Sale+OE | $47.48 | -88,695 | 171,164 | -34% | -$4,211,239 | |||||
| M | 2019-01-22 | MDXG | Mimedx Group, Inc. | Okumus Fund Management Ltd. | 10% | S - Sale | $2.81 | -1,991,700 | 21,066,710 | -9% | -$5,589,787 | |||||
2019-01-23 | DXCM | Dexcom Inc | Pacelli Steven Robert | EVP, Strategy, Corp. Dev. | S - Sale | $149.74 | -3,114 | 101,404 | -3% | -$466,303 | ||||||
2019-01-22 | LQDA | Liquidia Technologies Inc | Gordon Kevin K | Pres, CFO | S - Sale | $14.66 | -11,322 | 163,208 | -6% | -$165,942 | ||||||
| M | 2019-01-23 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.69 | +4,830 | 18,203,359 | 0% | +$3,337 | |||||
2019-01-18 | BAX | Baxter International Inc | Stallkamp Thomas T | Dir | S - Sale | $70.00 | -3,187 | 32,018 | -9% | -$223,090 | ||||||
| D | 2019-01-22 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale+OE | $54.18 | -6,000 | 4,750 | -56% | -$325,080 | |||||
| AM | 2019-01-17 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $53.90 | -289,405 | 906,934 | -24% | -$15,600,213 | |||||
| AM | 2019-01-14 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $49.31 | -300,704 | 1,196,339 | -20% | -$14,827,103 | |||||
| M | 2018-01-17 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $53.90 | -289,405 | 906,934 | -24% | -$15,600,213 | |||||
| D | 2019-01-18 | NVCR | Novocure Ltd | Groenhuysen Wilhelmus Cm | CFO | S - Sale+OE | $45.90 | -30,000 | 37,149 | -45% | -$1,376,910 | |||||
| D | 2019-01-18 | NVCR | Novocure Ltd | Danziger Asaf | CEO | S - Sale+OE | $45.91 | -46,863 | 171,164 | -21% | -$2,151,356 | |||||
| M | 2019-01-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.69 | +3,420 | 18,198,849 | 0% | +$2,370 | |||||
| D | 2019-01-16 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $45.00 | -20,000 | 60,000 | -25% | -$900,060 | |||||
| D | 2019-01-16 | NVCR | Novocure Ltd | Shah Pritesh | Chief Commercial Officer | S - Sale+OE | $45.00 | -25,000 | 17,087 | -59% | -$1,125,075 | |||||
| DM | 2019-01-16 | NVCR | Novocure Ltd | Danziger Asaf | CEO | S - Sale+OE | $45.16 | -200,000 | 171,164 | -54% | -$9,031,704 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |